Skip to main content

Travere Therapeutics, Inc.

TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438533

In the last 90 days, Travere Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 320 institutions reported holding it in 13F filings for Q2 2026, worth $5.98B in total; no superinvestor holds it.

13F holders, Q4 2022

Institutional positions in Travere Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
155
−14 vs. Q3 2022
Shares held
73.0M
+3.32M (+4.8%) vs. Q3 2022
Total value
$1.53B
−$180.9M (−10.5%) vs. Q3 2022
New holders
14
72 more added
Sold out
28
54 more reduced

2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TVTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2022: 155 institutions
Q1 2021: 150 institutionsQ2 2021: 136 institutionsQ3 2021: 148 institutionsQ4 2021: 169 institutionsQ1 2022: 169 institutionsQ2 2022: 171 institutionsQ3 2022: 171 institutionsQ4 2022: 155 institutionsQ1 2023: 175 institutionsQ2 2023: 169 institutionsQ3 2023: 169 institutionsQ4 2023: 165 institutionsQ1 2024: 175 institutionsQ2 2024: 174 institutionsQ3 2024: 178 institutionsQ4 2024: 197 institutionsQ1 2025: 218 institutionsQ2 2025: 213 institutionsQ3 2025: 238 institutionsQ4 2025: 278 institutionsQ1 2026: 261 institutionsQ2 2026: 320 institutions
Value heldQ4 2022: $1.53B
Q1 2021: $1.56BQ2 2021: $900.8MQ3 2021: $1.48BQ4 2021: $2.04BQ1 2022: $1.79BQ2 2022: $1.68BQ3 2022: $1.72BQ4 2022: $1.53BQ1 2023: $1.89BQ2 2023: $1.27BQ3 2023: $737.2MQ4 2023: $769.6MQ1 2024: $677.4MQ2 2024: $723.4MQ3 2024: $1.16BQ4 2024: $1.66BQ1 2025: $1.77BQ2 2025: $1.49BQ3 2025: $2.41BQ4 2025: $3.90BQ1 2026: $3.01BQ2 2026: $5.98B
Institutions holding TVTX and their total value by quarter
QuarterHoldersValue
Q2 2026320$5.98B
Q1 2026261$3.01B
Q4 2025278$3.90B
Q3 2025238$2.41B
Q2 2025213$1.49B
Q1 2025218$1.77B
Q4 2024197$1.66B
Q3 2024178$1.16B
Q2 2024174$723.4M
Q1 2024175$677.4M
Q4 2023165$769.6M
Q3 2023169$737.2M
Q2 2023169$1.27B
Q1 2023175$1.89B
Q4 2022155$1.53B
Q3 2022171$1.72B
Q2 2022171$1.68B
Q1 2022169$1.79B
Q4 2021169$2.04B
Q3 2021148$1.48B
Q2 2021136$900.8M
Q1 2021150$1.56B

Institutions, Q4 2022

Shares, value and share of portfolio for each institution holding Travere Therapeutics, Inc.; share changes are against Q3 2022.

Institutions holding TVTX in Q4 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Two Sigma Investments, LP200,011$4.21M0.01%+90,845+83.2%Added
UBS Group AG210,114$4.42M0.00%+167,838+397.0%Added
Bank of New York Mellon Corp213,223$4.48M0.00%−895−0.4%Reduced
Norges Bank215,000$4.52M0.00%−20,900−8.9%Reduced
Nuveen Asset Management, LLC184,068$4.54M0.00%−225,420−55.0%Reduced
Ameriprise Financial Inc228,988$4.82M0.00%+37,565+19.6%Added
GW&K Investment Management, LLC241,734$5.08M0.05%−2,104−0.9%Reduced
Connor, Clark & Lunn Investment Management Ltd.244,812$5.15M0.03%−2,037−0.8%Reduced
AXA S.A.271,212$5.70M0.02%−5,285−1.9%Reduced
Deutsche Bank AG276,427$5.81M0.00%−51,406−15.7%Reduced
MPM Oncology Impact Management LP281,711$5.92M1.54%+5,251+1.9%Added
Kennedy Capital Management, Inc.283,343$5.96M0.17%+117,114+70.5%Added
Sectoral Asset Management Inc292,320$6.15M1.19%+42,620+17.1%Added
Two Sigma Advisers, LP301,100$6.33M0.02%+92,000+44.0%Added
Polar Asset Management Partners Inc.317,290$6.67M0.10%−25,000−7.3%Reduced
Rafferty Asset Management, LLC319,454$6.72M0.06%+113,687+55.3%Added
Public Sector Pension Investment Board321,000$6.75M0.05%+167,000+108.4%Added
International Biotechnology Trust PLC379,019$7.96M2.46%+193,000+103.8%Added
Kynam Capital Management, LP418,099$8.79M1.35%+1,370+0.3%Added
Tekla Capital Management LLC418,520$8.80M0.33%+170,842+69.0%Added
Charles Schwab Investment Management Inc463,111$9.74M0.00%+269+0.1%Added
D. E. Shaw & Co., Inc.466,840$9.82M0.02%+90,997+24.2%Added
Great Point Partners LLC475,000$9.99M2.07%−491,108−50.8%Reduced
Artal Group S.A.500,000$10.5M0.61%+500,000New
Walleye Capital LLC507,083$10.7M0.23%+168,659+49.8%Added
Pictet Asset Management SA555,366$11.7M0.02%+142,855+34.6%Added
Bank of America Corp555,938$11.7M0.00%+122,520+28.3%Added
Invesco Ltd.556,676$11.7M0.00%+119,090+27.2%Added
Sofinnova Investments, Inc.578,268$12.2M0.74%+183,590+46.5%Added
Northern Trust Corp636,725$13.4M0.00%+4,580+0.7%Added
Morgan Stanley692,204$14.6M0.00%+319,136+85.5%Added
Laurion Capital Management LP834,961$17.6M0.49%00.0%Unchanged
Millennium Management LLC861,045$18.1M0.02%+262,046+43.7%Added
Assenagon Asset Management S.A.867,419$18.2M0.08%−57,095−6.2%Reduced
Healthcare of Ontario Pension Plan Trust Fund877,000$18.4M0.09%+121,000+16.0%Added
Jacobs Levy Equity Management, Inc884,262$18.6M0.13%+156,148+21.4%Added
Rock Springs Capital Management LP951,650$20.0M0.48%00.0%Unchanged
Citadel Advisors LLC954,094$20.1M0.02%−145,596−13.2%Reduced
Finepoint Capital LP1,026,300$21.6M6.98%−2,575−0.3%Reduced
Geode Capital Management, LLC1,097,011$23.1M0.00%+36,605+3.5%Added
JPMorgan Chase & Co1,222,958$25.7M0.00%+165,955+15.7%Added
Baker Bros. Advisors LP1,225,255$25.8M0.15%−2,074,754−62.9%Reduced
OrbiMed Advisors LLC1,253,130$26.4M0.50%00.0%Unchanged
Braidwell LP1,455,585$30.6M1.03%+1,455,585New
Renaissance Technologies LLC1,593,522$33.5M0.05%+86,100+5.7%Added
Adage Capital Partners GP, L.L.C.2,600,000$54.7M0.13%+250,000+10.6%Added
Goldman Sachs Group Inc2,640,146$55.5M0.02%+86,172+3.4%Added
Vanguard Group Inc3,515,446$73.9M0.00%+133,836+4.0%Added
Macquarie Group Ltd3,556,112$74.8M0.09%+245,856+7.4%Added
Ra Capital Management, L.P.3,984,681$83.8M1.70%−938,260−19.1%Reduced
State Street Corp4,224,024$88.8M0.01%+810,609+23.7%Added
Deep Track Capital, LP4,582,000$96.4M4.20%+582,000+14.5%Added
Janus Henderson Group PLC5,091,285$107.1M0.08%+1,178,800+30.1%Added
BlackRock Inc.5,094,388$107.1M0.00%+529,638+11.6%Added
Armistice Capital, LLC6,412,000$134.8M3.63%+576,000+9.9%Added
Point72 Asset Management, L.P.0$00.00%−327,706−100.0%Sold out
Moore Capital Management, LP0$00.00%−191,724−100.0%Sold out
State of New Jersey Common Pension Fund D0$00.00%−86,045−100.0%Sold out
BNP Paribas Arbitrage, SA0$00.00%−75,454−100.0%Sold out
Essex Investment Management Co LLC0$00.00%−57,605−100.0%Sold out
Ergoteles LLC0$00.00%−53,899−100.0%Sold out
Putnam Investments LLC0$00.00%−49,740−100.0%Sold out
Occudo Quantitative Strategies LP0$00.00%−36,821−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−27,964−100.0%Sold out
CSS LLC0$00.00%−26,891−100.0%Sold out
Engineers Gate Manager LP0$00.00%−17,762−100.0%Sold out
Victory Capital Management Inc0$00.00%−17,547−100.0%Sold out
Prudential Financial Inc0$00.00%−14,045−100.0%Sold out
AlphaCrest Capital Management LLC0$00.00%−12,107−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−11,814−100.0%Sold out
Jump Financial, LLC0$00.00%−10,757−100.0%Sold out
Trexquant Investment LP0$00.00%−10,579−100.0%Sold out
Caption Management, LLC0$00.00%−10,200−100.0%Sold out
Envestnet Asset Management Inc0$00.00%−10,025−100.0%Sold out
Simplex Trading, LLC0$00.00%−4,256−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−1,000−100.0%Sold out
Umb Bank N A0$00.00%−310−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−341−100.0%Sold out
Lindbrook Capital, LLC0$00.00%−223−100.0%Sold out
Allworth Financial LP0$00.00%−50−100.0%Sold out
Parallel Advisors, LLC0$00.00%−41−100.0%Sold out
Signaturefd, LLC0$00.00%−18−100.0%Sold out
Ellevest, Inc.0$00.00%−3−100.0%Sold out
Eaton Vance Management––––Not filed
FourThought Financial, LLC––––Not filed